Drugs for Solid Tumors Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 77187 | Published Date: Jan 2026 | No. of Page: 109 | Base Year: 2025 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL DRUGS FOR SOLID TUMORS INDUSTRY
    2.1 Summary about Drugs for Solid Tumors Industry
    2.2 Drugs for Solid Tumors Market Trends
        2.2.1 Drugs for Solid Tumors Production & Consumption Trends
        2.2.2 Drugs for Solid Tumors Demand Structure Trends
    2.3 Drugs for Solid Tumors Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Small Molecules
        4.2.2 Biologics
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Hospitals
        4.3.2 Clinics
        4.3.3 Academic and Research Institutes
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Small Molecules
        5.2.2 Biologics
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Hospitals
        5.3.2 Clinics
        5.3.3 Academic and Research Institutes
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Small Molecules
        6.2.2 Biologics
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Hospitals
        6.3.2 Clinics
        6.3.3 Academic and Research Institutes
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Small Molecules
        7.2.2 Biologics
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Hospitals
        7.3.2 Clinics
        7.3.3 Academic and Research Institutes
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Small Molecules
        8.2.2 Biologics
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Hospitals
        8.3.2 Clinics
        8.3.3 Academic and Research Institutes
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Small Molecules
        9.2.2 Biologics
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Hospitals
        9.3.2 Clinics
        9.3.3 Academic and Research Institutes
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Hoffmann-La Roche
        10.1.2 Novartis
        10.1.3 Celgene
        10.1.4 Johnson & Johnson
        10.1.5 Pfizer
        10.1.6 BMS
        10.1.7 Eli Lilly
        10.1.8 GSK
        10.1.9 Merck
        10.1.10 Sanofi
        10.1.11 AbbVie
        10.1.12 AstraZeneca
        10.1.13 Bayer
        10.1.14 Biogen
        10.1.15 Boehringer Ingelheim
        10.1.16 Boston Biomedical
        10.1.17 Daiichi Sankyo
    10.2  Drugs for Solid Tumors Sales Date of Major Players (2017-2020e)
        10.2.1 Hoffmann-La Roche
        10.2.2 Novartis
        10.2.3 Celgene
        10.2.4 Johnson & Johnson
        10.2.5 Pfizer
        10.2.6 BMS
        10.2.7 Eli Lilly
        10.2.8 GSK
        10.2.9 Merck
        10.2.10 Sanofi
        10.2.11 AbbVie
        10.2.12 AstraZeneca
        10.2.13 Bayer
        10.2.14 Biogen
        10.2.15 Boehringer Ingelheim
        10.2.16 Boston Biomedical
        10.2.17 Daiichi Sankyo
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
Table Drugs for Solid Tumors Product Type Overview
Table Drugs for Solid Tumors Product Type Market Share List
Table Drugs for Solid Tumors Product Type of Major Players
Table Brief Introduction of Hoffmann-La Roche
Table Brief Introduction of Novartis
Table Brief Introduction of Celgene
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Pfizer
Table Brief Introduction of BMS
Table Brief Introduction of Eli Lilly
Table Brief Introduction of GSK
Table Brief Introduction of Merck
Table Brief Introduction of Sanofi
Table Brief Introduction of AbbVie
Table Brief Introduction of AstraZeneca
Table Brief Introduction of Bayer
Table Brief Introduction of Biogen
Table Brief Introduction of Boehringer Ingelheim
Table Brief Introduction of Boston Biomedical
Table Brief Introduction of Daiichi Sankyo
Table Products & Services of Hoffmann-La Roche
Table Products & Services of Novartis
Table Products & Services of Celgene
Table Products & Services of Johnson & Johnson
Table Products & Services of Pfizer
Table Products & Services of BMS
Table Products & Services of Eli Lilly
Table Products & Services of GSK
Table Products & Services of Merck
Table Products & Services of Sanofi
Table Products & Services of AbbVie
Table Products & Services of AstraZeneca
Table Products & Services of Bayer
Table Products & Services of Biogen
Table Products & Services of Boehringer Ingelheim
Table Products & Services of Boston Biomedical
Table Products & Services of Daiichi Sankyo
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Drugs for Solid Tumors Market Forecast (Million USD) by Region 2021f-2026f
Table Global Drugs for Solid Tumors Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Drugs for Solid Tumors Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Drugs for Solid Tumors Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Drugs for Solid Tumors Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Drugs for Solid Tumors Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Drugs for Solid Tumors Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Drugs for Solid Tumors Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Drugs for Solid Tumors Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Drugs for Solid Tumors Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Drugs for Solid Tumors Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic and Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic and Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic and Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic and Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic and Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Small Molecules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Biologics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic and Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Hoffmann-La Roche 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Celgene 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of BMS 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Eli Lilly 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of GSK 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Merck 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of AbbVie 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of AstraZeneca 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Bayer 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Biogen 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Boehringer Ingelheim 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Boston Biomedical 2017-2020e
Figure Drugs for Solid Tumors Sales Revenue (Million USD) of Daiichi Sankyo 2017-2020e
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Drugs for Solid Tumors Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drugs for Solid Tumors Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drugs for Solid Tumors Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dry Ice Market

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope:  ... Read More